Article Versions Notes

Nantanee R, Jantarabenjakul W, Jaru-Ampornpan P, Sodsai P, Himananto O, Athipunjapong J, Sophonphan J, Nanthapisal S, Hirankarn N, Puthanakit T on behalf of the Study Team. A Randomized Clinical Trial of a Fractional Low Dose of BNT162b2 Booster in Adults Following AZD1222. Vaccines. 2022; 10(6):914. https://doi.org/10.3390/vaccines10060914

Nantanee, Rapisa, Watsamon Jantarabenjakul, Peera Jaru-Ampornpan, Pimpayao Sodsai, Orawan Himananto, Jitthiwa Athipunjapong, Jiratchaya Sophonphan, Sira Nanthapisal, Nattiya Hirankarn, and Thanyawee Puthanakit on behalf of the Study Team. 2022. "A Randomized Clinical Trial of a Fractional Low Dose of BNT162b2 Booster in Adults Following AZD1222" Vaccines 10, no. 6: 914. https://doi.org/10.3390/vaccines10060914

Nantanee, R., Jantarabenjakul, W., Jaru-Ampornpan, P., Sodsai, P., Himananto, O., Athipunjapong, J., Sophonphan, J., Nanthapisal, S., Hirankarn, N., & Puthanakit, T., on behalf of the Study Team. (2022). A Randomized Clinical Trial of a Fractional Low Dose of BNT162b2 Booster in Adults Following AZD1222. Vaccines, 10(6), 914. https://doi.org/10.3390/vaccines10060914